You are here
Argus Pharmaceuticals Inc
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
FEASIBILITY OF PRECLINICAL SCALEUP OF LIPOSOMAL TNF
Amount: $48,158.00IN THIS PHASE I EFFORT, WE WILL DEMONSTRATE THE ABILITY TO SCALE UP THE PRODUCTION OF A LEAD LIPOSOMAL FORMULATION CANDIDATE OF ACYLATED, LIPOPHILIC RHUTNF. WE WILL SUBJECT THE BACTERIAL RECOMBINANT P ...
SBIRPhase I1992Department of Health and Human Services -
DEVELOPMENT OF OPTIMUM CONDITIONS FOR NIMC PRODUCTION
Amount: $49,904.00MITOCHONDRIAL RESPIRATION INHIBITION IN TUMOR CELLS MAY OCCUR IN TWO MANNERS. ONE MECHANISM INVOLVES THE SYNTHESIS OF NITRIC OXIDE (NO) BY MACROPHAGES OR IFN-GAMMA MEDIATED INDUCTION OF NO SYNTHESIS I ...
SBIRPhase I1992Department of Health and Human Services -
ISOLATION AND EXPRESSION OF CDNA CLONES FOR RIF
Amount: $49,233.00CYTOTOXIC ACTIVATED MACROPHAGES SECRETE SOLUBLE FACTORS THAT HAVE A VARIETY OF EFFECTS ON TUMOR CELLS. INCLUDED IN THE TUMOR CELL RESPONSE ARE THE INHIBITION OF MITOCHONDRIAL RESPIRATION AND INHIBITIO ...
SBIRPhase I1991Department of Health and Human Services